Zai Lab Entered into an Exclusive License Agreement with Karuna Therapeutics to Develop and Commercialize KarXT (xanomeline-trospium) in Greater China
Shots: Karuna to receive $35M up front, ~$80M in development and regulatory milestones and is also eligible to receive ~$72M in sales milestones along with […]